GUPEA >
Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Clinical Sciences / Institutionen för kliniska vetenskaper >
Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper >

Prostate Cancer Screening: Outcomes and Risk Prediction


Please use this identifier to cite or link to this item: http://hdl.handle.net/2077/57825

Files in This Item:

File Description SizeFormat
gupea_2077_57825_1.pdfThesis frame9266KbAdobe PDF
View/Open
gupea_2077_57825_3.pdfAbstract145KbAdobe PDF
View/Open
Title: Prostate Cancer Screening: Outcomes and Risk Prediction
Authors: Frånlund, Maria
E-mail: maria.franlund@vgregion.se
Issue Date: 12-Dec-2018
University: University of Gothenburg. Sahlgrenska Academy
Institution: Institute of Clinical Sciences. Department of Urology
Parts of work: I. The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial Maria Frånlund, Sigrid Carlsson, Johan Stranne, Gunnar Aus and Jonas Hugosson. BJU Int. 2012 Sep;110(5):638-43.
VIEW ARTICLE


II. Prostate cancer risk assessment in men with an initial PSA below 3 ng/mL: results from the Göteborg randomized population-based prostate cancer screening trial. Maria Frånlund, Rebecka Arnsrud Godtman, Sigrid Carlsson, Hans Lilja, Marianne Månsson, Johan Stranne and Jonas Hugosson Scand J Urol. 2018 Sep 21:1–7. [Epub ahead of print]
VIEW ARTICLE


III. Improving Prostate Cancer Screening: 22-Year Follow-up in a Randomized Trial. Maria Frånlund, Marianne Månsson, Rebecka Arnsrud Godtman, Gunnar Aus, Erik Holmberg, Pär Lodding, Carl-Gustav Pihl, Johan Stranne, Hans Lilja and Jonas Hugosson (submitted)

IV. Prostate Cancer Risk after Stop Age in Men Participating in a Long-Term Screening Programme: Results from the Göteborg Randomised Population-Based Prostate Cancer Screening Trial. Maria Frånlund, Marianne Månsson, Rebecka Arnsrud Godtman, Anna Grenabo, Johan Stranne, Hans Lilja and Jonas Hugosson (manuscript)
Date of Defence: 2019-01-18
Disputation: Fredagen den 18 januari 2019, Kl. 9.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3, Göteborg
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: prostate cancer
screening
outcomes
risk prediction
prostate-specific antigen
Abstract: Prostate Cancer Screening: Outcomes and Risk Prediction Maria Frånlund, MD Department of Urology, Institute of Clinical Sciences Sahlgrenska Academy at University of Gothenburg, Sweden ABSTRACT The Göteborg Randomized Population-Based Prostate Cancer (PC) screening trial was started in 1995 to evaluate prostate-specific antigen (PSA) screening and its long-term impact on PC-specific mortality and PC incidence. The four papers included in this thesis present the outcomes of PSA-based screeni... more
ISBN: 978-91-7833-121-5 (PRINT)
978-91-7833-122-2 (PDF)
URI: http://hdl.handle.net/2077/57825
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper

 

 

© Göteborgs universitet 2011